Generics are not required to replicate the extensive clinical trials that have already been used in the development of the original, brand-name drug. These tests usually involve a few hundred to a few thousand patients.
Since the safety and efficacy of the brand-name product has already been well established in clinical testing and frequently many years of patient use, it is scientifically unnecessary, and would be unethical, to require that such extensive testing be repeated in human subjects for each generic drug that a firm wishes to market. Instead, generic applicants must scientifically demonstrate that their product is bioequivalent (i.e., performs in the same manner) to the pioneer drug.
One way scientists demonstrate bioequivalence is to measure the time it takes the generic drug to reach the bloodstream and its concentration in the bloodstream in 24 to 36 healthy, normal volunteers.
This gives them the rate and extent of absorption-or bioavailability-of the generic drug, which they then compare to that of the pioneer drug. The generic version must deliver the same amount of active ingredients into a patient's bloodstream in the same amount of time as the pioneer drug.
As well as some common Myths about generics:
MYTH: Generics take longer to act in the body.
FACT: The firm seeking to sell a generic drug must show that its drug delivers the same amount of active ingredient in the same timeframe as the original product.
MYTH: Generics are not as potent as brand-name drugs.
FACT: FDA requires generics to have the same quality, strength, purity, and stability as brand-name drugs.
MYTH: Generics are not as safe as brand-name drugs.
FACT: FDA requires that all drugs be safe and effective and that their benefits outweigh their risks. Since generics use the same active ingredients and are shown to work the same way in the body, they have the same risk-benefit profile as their brand-name counterparts.
MYTH: Brand-name drugs are made in modern manufacturing facilities, and generics are often made in substandard facilities.
FACT: FDA won't permit drugs to be made in substandard facilities. FDA conducts about 3,500 inspections a year in all firms to ensure standards are met. Generic firms have facilities comparable to those of brand-name firms. In fact, brand-name firms account for an estimated 50 percent of generic drug production. They frequently make copies of their own or other brand-name drugs but sell them without the brand name.
MYTH: Generic drugs are likely to cause more side effects. FACT: There is no evidence of this. FDA monitors reports of adverse drug reactions and has found no difference in the rates between generic and brand-name drugs.View Thread
There are different Pharmaceutical laboratories that makes these medicines...there is also brand name or generics...
So you can't compare pill sizes either...all medicines have both an active (in this case Oxycodone) ingredient, and inactive ingredients..(fillers)....so a pill of the same mg by two different makers can be different sizes as well dependent on the fillers and the way it's made..some are more 'compact' than others...
Some people claim that a brand name is better...or some people claim that one generic is better/stronger than another...This physically can't be true as all brands and generics by law have to have the exact same amount of the active ingredient. The law only states that the 'filler' can be or - 20%...
So...all that being said...LOL...if you 'feel' more pain relief by taking 2 of the 5mg than the 10mg...then speak with your Dr...to me...I want to always take the least amount of medicine per day....so if let's say your total dosage is 40mg...I would rather take 1 10mg pill every 6 hours then 8 of the 5mgs.....as well as I am self pay without insurance....I always go for what is least expensive..
I'm thinking that you may be subliminally thinking it's less effective based on the size of the pill...but hey...whatever you and your Dr. decide..View Thread